Most Recent Articles about LLY
3 Biotech Stocks With a Lot to Prove at ASH 2019 https://www.fool.com/investing/2019/12/02/3-biotech-stocks-with-a-lot-to-prove-at-ash-2019.aspx?source=iedfolrf0000001 Dec 02, 2019 - These companies have some important presentations scheduled for the last big oncology conference of the year.
Top Research Reports for Merck, Eli Lilly & Charter Communications http://www.zacks.com/research-daily/643445/top-research-reports-for-merck-eli-lilly-charter-communications?cid=CS-ZC-FT-research_daily-643445 Nov 27, 2019 - Top Research Reports for Merck, Eli Lilly & Charter Communications
Alkermes Submits NDA to FDA for Schizophrenia & Bipolar I Drug http://www.zacks.com/stock/news/629205/alkermes-submits-nda-to-fda-for-schizophrenia-bipolar-i-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-629205 Nov 20, 2019 - Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
SNY Sanofi NYSE $43.75 $109.14B
ABT Abbott Laboratories NYSE $67.67 $118.71B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals